Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 4
2003 1
2004 3
2005 4
2006 3
2007 4
2008 3
2009 5
2010 7
2011 8
2012 7
2013 8
2014 11
2015 10
2016 13
2017 9
2018 13
2019 16
2020 45
2021 50
2022 49
2023 30
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience.
Russo A, Gullì SP, D'Avino A, Borrazzo C, Carannante N, Dezza FC, Covino S, Polistina G, Fiorentino G, Trecarichi EM, Mastroianni CM, Torti C, Oliva A. Russo A, et al. Int J Antimicrob Agents. 2024 Apr 30:107190. doi: 10.1016/j.ijantimicag.2024.107190. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38697579
COVID-19 vaccination in cancer patients: Immune responses one year after the third dose.
Campagna R, Dominelli F, Zingaropoli MA, Ciurluini F, Grilli G, Amoroso A, De Domenico A, Amatore D, Lia MS, Cortesi E, Picone V, Mastroianni CM, Ciardi MR, De Santis R, Lista F, Antonelli G, Turriziani O. Campagna R, et al. Vaccine. 2024 Apr 11;42(10):2687-2694. doi: 10.1016/j.vaccine.2024.03.017. Epub 2024 Mar 17. Vaccine. 2024. PMID: 38499458 Free article.
Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyperactivation and are associated with high platelet-lymphocyte and low platelet-neutrophil aggregates.
Maiorca F, Lombardi L, Marrapodi R, Pallucci D, Sabetta A, Zingaropoli MA, Perri V, Flego D, Romiti GF, Corica B, Miglionico M, Russo G, Pasculli P, Ciardi MR, Mastroianni CM, Ruberto F, Pugliese F, Pulcinelli F, Raparelli V, Cangemi R, Visentini M, Basili S, Stefanini L. Maiorca F, et al. Among authors: mastroianni cm. Res Pract Thromb Haemost. 2023 Nov 14;7(8):102262. doi: 10.1016/j.rpth.2023.102262. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193050 Free PMC article.
Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study.
Rando E, Salvati F, Sangiorgi F, Catania F, Leone E, Oliva A, Di Gennaro F, Fiori B, Cancelli F, Figliomeni S, Bobbio F, Sacco F, Bavaro DF, Diella L, Belati A, Saracino A, Mastroianni CM, Fantoni M, Murri R. Rando E, et al. J Antimicrob Chemother. 2024 Feb 1;79(2):453-461. doi: 10.1093/jac/dkad404. J Antimicrob Chemother. 2024. PMID: 38169441 Free PMC article.
Corrigendum to "Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation" [Clin Microbiol Infect 28 (12) (2022 Dec) 1657-1658].
Antonelli G, Focosi D, Turriziani O, Tuccori M, Brandi R, Fillo S, Ajassa C, Lista F, Mastroianni CM. Antonelli G, et al. Among authors: mastroianni cm. Clin Microbiol Infect. 2024 Mar;30(3):408. doi: 10.1016/j.cmi.2023.12.014. Epub 2023 Dec 14. Clin Microbiol Infect. 2024. PMID: 38103639 Free PMC article. No abstract available.
A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.
Fedele G, Schiavoni I, Trentini F, Leone P, Olivetta E, Fallucca A, Fiore S, Di Martino A, Abrignani S, Baldo V, Baldovin T, Bandera A, Clerici P, De Paschale M, Diaco F, Domnich A, Fortunato F, Giberti I, Gori A, Grifantini R, Lazzarotto T, Lodi V, Mastroianni CM, Prato R, Restivo V, Vitale F, Brusaferro S, Merler S, Palamara AT, Stefanelli P; Study Group for the Immunological Monitoring post Covid19 vaccination. Fedele G, et al. Front Immunol. 2023 Nov 20;14:1272119. doi: 10.3389/fimmu.2023.1272119. eCollection 2023. Front Immunol. 2023. PMID: 38077369 Free PMC article.
276 results